1. Eli Lilly lowers insulin costs as coronavirus crisis deepens— IQVIA launches new COVID-19 trial matching service — Inovio begins clinical trial of COVID-19 vaccine — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

DBV's peanut prevention patch approaches key stage of approval process

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Feb 21, 2020 at 10:42 AM.

  1. cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    14,785
    Likes Received:
    3
    via Almost a year and a half after DBV Technologies pulled its peanut allergy immunotherapy patch from FDA review, the biotech will get their day in court. The FDA has scheduled an advisory committee hearing for May 15.

    article source